Cargando…

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study

Chronic lymphocytic leukemia (CLL) is a hematological disorder with complex clinical and biological behavior. TP53 mutational status and cytogenetic assessment of the deletion of the corresponding locus (17p13.1) are considered the most relevant biomarkers associated with pharmaco‐predictive respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Luca, Giuseppa, Cerruti, Giannamaria, Lastraioli, Sonia, Conte, Romana, Ibatici, Adalberto, Di Felice, Nikki, Morabito, Fortunato, Monti, Paola, Fronza, Gilberto, Matis, Serena, Colombo, Monica, Fabris, Sonia, Ciarrocchi, Alessia, Neri, Antonino, Menichini, Paola, Ferrarini, Manlio, Nozza, Paolo, Fais, Franco, Cutrona, Giovanna, Dono, Mariella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086786/ https://www.ncbi.nlm.nih.gov/pubmed/35961859 http://dx.doi.org/10.1002/hon.3063

Ejemplares similares

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
por: Monti, Paola, et al.
Publicado: (2020)

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells
por: Matis, Serena, et al.
Publicado: (2022)

Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
por: Menichini, Paola, et al.
Publicado: (2021)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
por: Ronchetti, Domenica, et al.
Publicado: (2020)

LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells
por: Matis, Serena, et al.
Publicado: (2021)

Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines
por: Giannoni, Paolo, et al.
Publicado: (2020)

Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling
por: De Luca, Giuseppa, et al.
Publicado: (2020)

A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation
por: Giannoni, Paolo, et al.
Publicado: (2022)

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients
por: Dono, Mariella, et al.
Publicado: (2019)

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
por: Morabito, Fortunato, et al.
Publicado: (2021)

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia
por: Ronchetti, Domenica, et al.
Publicado: (2013)

Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements
por: Bagnara, Davide, et al.
Publicado: (2022)

Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
por: Maura, Francesco, et al.
Publicado: (2011)

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
por: Bagnara, Davide, et al.
Publicado: (2022)

Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia
por: Maura, Francesco, et al.
Publicado: (2015)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
por: Agathangelidis, Andreas, et al.
Publicado: (2023)

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
por: Biatta, Chiara M., et al.
Publicado: (2023)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy
por: Morabito, Fortunato, et al.
Publicado: (2023)

Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
por: Colombo, Monica, et al.
Publicado: (2020)

Mutant p53(K120R) expression enables a partial capacity to modulate metabolism
por: Monti, Paola, et al.
Publicado: (2022)

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells
por: De Cecco, Loris, et al.
Publicado: (2015)

ΔN-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites
por: Monti, Paola, et al.
Publicado: (2014)

Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival
por: Foggetti, Giorgia, et al.
Publicado: (2019)

Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay
por: Monti, Paola, et al.
Publicado: (2021)

Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients
por: Ravera, Silvia, et al.
Publicado: (2020)

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
por: Ronchetti, D, et al.
Publicado: (2016)

Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
por: Giessler, Klara M., et al.
Publicado: (2017)

CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
por: Cutrona, G, et al.
Publicado: (2002)

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
por: Andreotti, Virginia, et al.
Publicado: (2011)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Accurate Identification of Subclones in Tumor Genomes
por: Ahmadinejad, Navid, et al.
Publicado: (2022)

Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
por: Sun, Stella, et al.
Publicado: (2011)

Copy-scAT: Deconvoluting single-cell chromatin accessibility of genetic subclones in cancer
por: Nikolic, Ana, et al.
Publicado: (2021)

P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development
por: Monti, Paola, et al.
Publicado: (2019)

Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)

Relapse-Fated Subclones: Finding the Needle in the Haystack
por: Tesio, Melania
Publicado: (2020)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
por: Rampias, Theodoros
Publicado: (2020)

Central nervous system involvement in mycosis fungoides: relevance of tcr gene testing in cerebrospinal fluid
por: Giorli, Elisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2aojvsp4aefil53eh0s9imsp4h